Live Breaking News & Updates on Olve Cmnd Ca1850532047

Stay updated with breaking news from Olve cmnd ca1850532047. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100 in Patients with Alcohol Use Disorder

Tel Aviv, Israel / Vancouver, Canada, May 22, 2023 Clearmind Medicine Inc. , , a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major. | May 22, 2023 ....

New York , United States , Tel Aviv , Adi Zuloff Shani , Yale School Of Medicine , Frankfurt Stock Exchange , Canadian Securities Exchange , Ethics Committee , Yale School Of Medicine Department Psychiatry , Medicine Inc , Exchange Commission , Clearmind Medicine Inc , Mount Sinai West Icahn School Of Medicine , Yale School , Anahita Bassir Nia , Assistant Professor , Mount Sinai Beth Israel , Mount Sinai West , Icahn School , Chief Executive Officer , Bassir Nia , Private Securities Litigation Reform Act , Clearmind Medicine Inc Stock Exchange , Press Release , Olve Cmnd Ca1850532047 ,

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Tel Aviv, Israel / Vancouver, Canada, May 19, 2023 Clearmind Medicine Inc. , , a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major. | May 19, 2023 ....

Tel Aviv , Clearmind Medicine Inc , Exchange Commission , Medicine Inc , Frankfurt Stock Exchange , Nasdaq Stock Market , Canadian Securities Exchange , Company Nasdaq , Nasdaq Listing Rule , Nasdaq Capital Market , Private Securities Litigation Reform Act , Clearmind Medicine Inc Stock Exchange , Press Release , Olve Cmnd Ca1850532047 ,

Clearmind Medicine Engages Experienced Contract Research Organization to Support its First-in-Human Clinical Trial

Tel Aviv, Israel / Vancouver, Canada, April 20, 2023 Clearmind Medicine Inc. , , a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major. | April 20, 2023 ....

Tel Aviv , British Columbia , Adi Zuloff Shani , Canadian Securities Exchange , Globenewswire Inc , Exchange Commission , Clearmind Medicine Inc , Medicine Inc , Frankfurt Stock Exchange , Alcohol Use Disorder , Chief Executive , Stock Exchange , Private Securities Litigation Reform Act , Clearmind Medicine Inc Stock Exchange , Press Release , Olve Cmnd Ca1850532047 ,

Israeli Biotech Clearmind Medicine Announces Positive Pre-Clinical Results Treating Major Depression With a Novel Ketamine-Based Compound

Tel Aviv, Israel / Vancouver, Canada, Jan. 31, 2023 Clearmind Medicine Inc. , , a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major. | January 31, 2023 ....

United States , Tel Aviv , Gal Yadid , Adi Zuloff Shani , Clearmind Medicine Inc , Ilan University , Frankfurt Stock Exchange , Exchange Commission , Trademark Office , Medicine Inc , Canadian Securities Exchange , Gonda Multidisciplinary Brain Research Center , Bar Ilan University , Professor Gal Yadid , Major Depressive Disorder , United States Patent , Flinders Sensitive Line , Both Ketamine , Private Securities Litigation Reform Act , Clearmind Medicine Inc Stock Exchange , Press Release , Olve Cmnd Ca1850532047 ,